MDMA Assisted Therapy

Learn about current research and regulations

MDMA Assisted Therapy

Learn about current research and regulations

MDMA has been explored as an adjunct to therapy since the 1970s, particularly in cases where traditional approaches like antidepressants or talk therapy have not been effective. While research into its safety and efficacy continues, MDMA remains a controlled substance in Canada and is not legally available to the general public.

MDMA-Assisted Therapy & Its Emerging Potential

MDMA-assisted therapy is currently being studied in clinical trials as a promising approach for trauma-related conditions, particularly post-traumatic stress disorder (PTSD). In these studies, MDMA is combined with psychotherapy in carefully controlled environments to explore how it may support emotional healing and personal insight.

Participants in research settings have reported experiences of increased empathy, reduced fear, and a greater ability to engage with difficult memories – qualities that may support deeper therapeutic work when guided by trained professionals.

While MDMA-assisted therapy is not currently available to the public in Canada, this growing body of research is helping shape the future of trauma-informed care and psychedelic-assisted therapy more broadly.

Clinical studies are examining how MDMA may support:

Ready to get started?

As you book an information call, we invite you to review these important considerations. They play a role in determining your eligibility for treatment. Your attention to these questions will help us better understand your needs and supports for your journey.

Schedule a free Information
Call to get started

Disclaimer

MDMA has not received approval from Health Canada or the Food and Drug Administration for treating any mental health conditions. This page offers information strictly for educational purposes and does not comprehensively cover the current research on psychedelic treatments, including their effectiveness, contraindications, risks, side effects, or other relevant details. For further information, please refer to our Disclaimers in our
Terms of Use.